1058 Design and Implementation of an Optimized ePRO System for Thoracic Surgery Patients (Recovery Monitor): a study protocol Amanda Gentry 1 , Meghan OLeary 2 , Allison Deal 3 , Jennifer Leeman 4 , Ethan Basch 3 , Chase Cox 5 , Kacee Little 3 , Jason Long 1 , Ben Haithcock 1 , Lauren Hill 6 , Gita Mody 1 1 University of North Carolina, Chapel Hill, North Carolina, USA, 2 UNC Gillings School of Public Health, Chapel Hill, North Carolina, USA, 3 UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA, 4 UNC School of Nursing, Chapel Hill, North Carolina, USA, 5 UNC School of Medicine, Chapel Hill, North Carolina, USA, 6 UNC Health, Chapel Hill, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1058 Aims Thoracic surgery often leads to significant postoperative complications and symptom burden due to the complexity of the procedures and patients comorbidities
However, Retatrutide is not a registered, approved pharmaceutical product, and it is not registered with Thailands FDA as an approved medicine
These calculations vary based on vial concentration, which is why the semaglutide dosage calculator exists
These reports are not proof that semaglutide directly caused the problem, but they do suggest the need for careful monitoring, especially in people with other risk factors
A semaglutide regimen will also lead to healthier blood sugar levels
